These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13466788)

  • 1. [Recurrent polyarthritis with alopecia, Raynaud's syndrome and positive L. E. test; remarks on the nosological problem of recurrent rheumatism].
    PIGUET B
    Rev Rhum Mal Osteoartic; 1957 Apr; 24(4):303-10. PubMed ID: 13466788
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recurrent diffuse alopecia, Raynaud's syndrome and recurrent polyarthritis with positive L.E. test].
    PIGUET B
    Bull Soc Fr Dermatol Syphiligr; 1956; 63(4):419-21. PubMed ID: 13396493
    [No Abstract]   [Full Text] [Related]  

  • 3. [Raynaud's syndrome in systemic lupus erythematosus and rheumatoid arthritis].
    Balaban SIa; Erov NK
    Revmatologiia (Mosk); 1986; (1):29-32. PubMed ID: 3520764
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mucocutaneous lesions in patients with systemic lupus erythematosus].
    Saurit V; Campana R; Ruiz Lascano A; Ducasse C; Bertoli A; Agüero S; Alvarellos A; Caeiro F
    Medicina (B Aires); 2003; 63(4):283-7. PubMed ID: 14518140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with headache in patients with systemic lupus erythematosus.
    Weder-Cisneros ND; Téllez-Zenteno JF; Cardiel MH; Guibert-Toledano M; Cabiedes J; Velásquez-Paz AL; García-Ramos G; Cantú C
    Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HEREDITARY FACTORS IN DISSEMINATED LUPUS ERYTHEMATOSUS. CLINICAL AND SEROLOGICAL FAMILIAL INVESTIGATIONS].
    THIVOLET J; VERJUS F; KRATCHKO A
    Ann Dermatol Syphiligr (Paris); 1964; 91():361-78. PubMed ID: 14194827
    [No Abstract]   [Full Text] [Related]  

  • 7. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
    Annese V; Tomietto P; Venturini P; D'Agostini S; Ferraccioli G
    Reumatismo; 2006; 58(1):50-8. PubMed ID: 16639488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
    Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
    Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Raynaud's phenomenon in chronic polyarthritis].
    Wittenborg A; Gille J; Ostertag H; Wagner HH; Alexander K
    Verh Dtsch Ges Rheumatol; 1976; 4():459-63. PubMed ID: 997826
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage.
    Appenzeller S; Costallat LT
    Cephalalgia; 2004 Dec; 24(12):1024-30. PubMed ID: 15566416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simple, sensitive & reliable method of releasing L.E. phenomenon by mechanical damage to leukocytes of the substratum with special reference to findings in lupus erythematosus and in chronic polyarthritis].
    MARMONT A; PIUMA MA; CAPPONI G
    Schweiz Med Wochenschr; 1957 Oct; 87(39-40):1253-7. PubMed ID: 13486002
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
    Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
    Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between the presence of cryoglobulins and Raynaud's syndrome. (Observations on a clinical case)].
    Lazarovics A; Pop E; Lazăr A; Barbu L
    Med Interna (Bucur); 1965 Oct; 17(10):1257-60. PubMed ID: 5862282
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of the L.E. phenomenon in chronic evolutive polyarthritis.
    GOSLINGS J; HIJMANS W
    J Belge Med Phys Rhumatol; 1958; 13(2):113-25. PubMed ID: 13563425
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical studies of the L.E. phenomenon in chronic evolutive polyarthritis].
    GOSLINGS J
    Reumatismo; 1958; 10(1):1-6. PubMed ID: 13554963
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systemic lupus erythematosus and anaemia].
    Falcão S; Barros R; Mateus M; Nero P; de Matos AA; Pimentão JB; Ribeiro I; Weigert A; Branco JC
    Acta Reumatol Port; 2007; 32(1):73-9. PubMed ID: 17450768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PERIPHERAL VASCULAR SYNDROMES ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
    ALARCON SEGOVIA D; OSMUNDSON PJ
    Ann Intern Med; 1965 May; 62():907-19. PubMed ID: 14288970
    [No Abstract]   [Full Text] [Related]  

  • 19. [Raynaud's syndrome and scleroderma. I. Scleroderma-like changes in Raynaud's syndrome and their differentiation from scleroderma].
    JABLONSKA S; LUKASIAK B; BUBNOW B
    Pol Tyg Lek (Wars); 1957 Sep; 12(39):1481-6. PubMed ID: 13505250
    [No Abstract]   [Full Text] [Related]  

  • 20. [Definition and terminology of Raynaud's syndrome].
    Heidrich H
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1742-4. PubMed ID: 18696408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.